Is it possible to use a genetic test to predict an individual’s risk of severe infection requiring hospitalization or death from SARS-CoV-2? That is the claim of Australian-based molecular diagnostics company Genetic Technologies Limited. It recently announced an agreement with U.S.-based Infinity BiologiX LLC (IBX) to sell its “COVID-19 Severe Disease Risk Test” to consumers […]
To access this post, you must purchase The Dark Report.